No. 23-267

Marilyn Williams v. Boehringer Ingelheim Pharmaceuticals, Inc., et al.

Lower Court: Eleventh Circuit
Docketed: 2023-09-20
Status: Denied
Type: Paid
Response RequestedResponse WaivedRelisted (2) Experienced Counsel
Tags: appellate-jurisdiction circuit-split civil-procedure final-decision interlocutory-ruling rule-41 rule-41(a) voluntary-dismissal
Key Terms:
JusticiabilityDoctri Jurisdiction
Latest Conference: 2024-02-16 (distributed 2 times)
Question Presented (AI Summary)

Does an interlocutory ruling that dismisses some (but not all) of a plaintiff's claims with prejudice become an appealable 'final decision' if the plaintiff voluntarily dismisses her action under Rule 41(a)?

Question Presented (from Petition)

QUESTION PRESENTED Petitioner Marilyn Williams is the latest victim ensnared by the “finality trap,” which has confounded the lower courts for decades. The typical fact pattern is on display here. Ms. Williams brought five claims against the respondents. The district court dismissed all claims, four without prejudice, and one with prejudice and without leave to re-plead after finding it preempted by federal law. But to Ms. Williams, the game of litigation was not worth the candle without that claim restored. So she responded by filing an amended pleading that dropped all of her other claims, asserting only the claim that the district court found preempted. Then Ms. Williams dismissed her action under Rule 41(a) and appealed the district court’s preemption ruling. The Eleventh Circuit dismissed for want of jurisdiction, holding that Ms. Williams had not appealed a “final decision” within the meaning of 28 U.S.C. § 1291. The ruling deepens a longstanding circuit split over the construction of those statutory words. And the sharp disagreement among the lower courts is not academic. There is no doubt that, had Ms. Williams been before different courts of appeals, they would have wielded judicial power. The question presented is: Does an interlocutory ruling that dismisses some (but not all) of a plaintiff’s claims with prejudice become an appealable “final decision” if the plaintiff voluntarily dismisses her action under Rule 41(a)? (i)

Docket Entries

2024-02-20
Petition DENIED.
2024-01-10
DISTRIBUTED for Conference of 2/16/2024.
2024-01-04
2023-12-21
Brief of respondents Boehringer Ingelheim Pharmaceuticals, Inc. et al. in opposition filed.
2023-11-14
Motion to extend the time to file a response is granted and the time is extended to and including December 22, 2023.
2023-11-13
Motion to extend the time to file a response from December 6, 2023 to December 22, 2023, submitted to The Clerk.
2023-11-06
Response Requested. (Due December 6, 2023)
2023-11-01
DISTRIBUTED for Conference of 11/17/2023.
2023-10-16
Waiver of right of respondents Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp. to respond filed.
2023-09-15
Petition for a writ of certiorari filed. (Response due October 20, 2023)
2023-07-27
Application (23A79) granted by Justice Thomas extending the time to file until September 15, 2023.
2023-07-25
Application (23A79) to extend the time to file a petition for a writ of certiorari from August 16, 2023 to October 15, 2023, submitted to Justice Thomas.

Attorneys

Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corp.
Paul Alessio MezzinaKing & Spalding LLP, Respondent
Paul Alessio MezzinaKing & Spalding LLP, Respondent
Marilyn Williams
Ashley Conrad KellerKeller Postman LLC, Petitioner
Ashley Conrad KellerKeller Postman LLC, Petitioner
Jonathan F. MitchellMitchell Law PLLC, Petitioner
Jonathan F. MitchellMitchell Law PLLC, Petitioner